My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Novo Nordisk A/S Common Stock (NY:NVO)

39.65 -7.77 (-16.40%)

Streaming Delayed Price Updated: 2:58 PM EST, Feb 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Novo Nordisk A/S Common Stock

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

99 100 Next >

This Biotech Stock Could Soar on Upcoming Clinical Data ↗

August 04, 2025

This weight loss drugmaker may be significantly undervalued right now.

Via The Motley Fool

Stock Market Today: US Stocks Likely To Open Higher Despite Weak Jobs Report—Palantir, Vertex Pharma In Focus ↗

August 04, 2025

US stock futures are up on Monday after ending Friday deep in the red, following a disappointing jobs report by Bureau of Labor Statistics.

Via Benzinga

Pfizer's Ascent Signals Broader Health Sector Resilience Amidst Innovation Wave

August 04, 2025

In a notable shift, shares of Pfizer (NYSE: PFE) have recently edged higher, reflecting a burgeoning strength within the broader health sector. This uptick signals a renewed investor confidence in the...

Via MarketMinute

Novo Nordisk, United Parcel Service, And Moderna Are Among Top 10 Large Cap Losers Last Week (July 28-August 1): Are The Others In Your Portfolio? ↗

August 03, 2025

Ten large-cap stocks, including Novo Nordisk and UPS, tumbled last week on weak earnings and guidance cuts.

Via Benzinga

Why Is Novo Nordisk Stock Crashing, and Is It a Buying Opportunity? ↗

August 02, 2025

Competition from all sides is causing Novo Nordisk to revise its expectations for 2025.

Via The Motley Fool

Benzinga Bulls And Bears: Celestica, Carvana, Novo Nordisk — And Fed Holds Rates Despite Trump Pressure ↗

August 02, 2025

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Via Benzinga

Topics Economy Government

Why Eli Lilly Stock Topped the Market Today ↗

August 01, 2025

Zepbound could benefit handsomely if an apparently planned government program is implemented.

Via The Motley Fool

Topics Government

Why Novo Nordisk Stock Bumped Higher on Friday ↗

August 01, 2025

There might be a new way for certain users to defray their costs for obesity treatments.

Via The Motley Fool

Topics Government

Will Hims & Hers Fall Along With Novo Nordisk? ↗

August 01, 2025

Novo Nordisk shares are trading as low as 35% of their 52-week highs, making Hims & Hers investors nervous whether a selloff is coming.

Via MarketBeat

Why Novo Nordisk Stock Imploded This Week ↗

August 01, 2025

Could this be a buying opportunity amid historically low valuations?

Via The Motley Fool

Eli Lilly, Novo Nordisk Shares Rally As Trump Administration Reportedly Plans To Experiment Including Weight-loss Drugs Under Medicaid, Medicare ↗

August 01, 2025

The Washington Post reported on Friday that state Medicaid programs and Medicare Part D insurance plans will be able to voluntarily choose to cover Ozempic, Wegovy, Mounjaro, and Zepbound for patients...

Via Stocktwits

Topics Government

Novo Nordisk's Alhemo Wins FDA Nod, Expanding Subcutaneous Option For Hemophilia Patients ↗

August 01, 2025

FDA approves Novo Nordisk's Alhemo for hemophilia A and B without inhibitors, following strong Phase 3 results showing reduced bleeding episodes.

Via Benzinga

Trump Administration Plan Signals Shift Toward Weight-Loss Drug Coverage For Medicare Patients ↗

August 01, 2025

The Trump administration is planning a five-year test allowing states to cover weight-loss drugs like Ozempic and Wegovy under Medicare and Medicaid programs.

Via Benzinga

Topics Government

Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines ↗

August 01, 2025

Regeneron Q2 revenue rose 4% to $3.68 billion, driven by Dupixent and antibody profits, while FDA delays impacted Eylea HD and odronextamab approvals.

Via Benzinga

Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...' ↗

August 01, 2025

President Donald Trump has issued a 60-day ultimatum to 17 major pharmaceutical companies, demanding that they lower drug prices in the U.S. or face severe consequences.

Via Benzinga

Topics Government

Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch ↗

July 31, 2025

Via Stocktwits

Topics Government

Why Novo Nordisk Stock Crumbled Again Today ↗

July 31, 2025

The company is still being punished for slicing its guidance.

Via The Motley Fool

Eli Lilly Obesity Drug Mounjaro Beats Legacy Trulicity On Cardio-Renal Health ↗

July 31, 2025

Eli Lilly's Mounjaro matched Trulicity in heart outcomes and showed added benefits on A1C, weight, kidney function, and mortality in a major trial.

Via Benzinga

Why Novo Nordisk Stock Plummeted Today ↗

July 30, 2025

Wall Street is reacting with downgrades to Novo's earnings, but with shares trading at their lowest valuation in years, patient investors could find opportunity as the stock falls.

Via The Motley Fool

Topics Stocks

Novo Nordisk Hit With Stock Downgrades After Lowering Full-Year Outlook: But Retail Is Optimistic On Company’s Profitability ↗

July 30, 2025

Barclays downgraded Novo to ‘Equal Weight’ from ‘Overweight’ with a price target of DKK 375, down from DKK 700.

Via Stocktwits

This Union Pacific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗

July 30, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

July 30, 2025

Via Benzinga

Novo Nordisk Stock Hits New 52-Week Low Amid Profit Warning: What Investors Need To Know ↗

July 30, 2025

Shares of Novo Nordisk are trading lower Wednesday morning. The stock is extending a dramatic sell-off from Tuesday's session.

Via Benzinga

Novo Nordisk Stock Is Plummeting. Time to Panic, or Is This an Opportunity? ↗

July 30, 2025

NVO stock is now down 65% from last year's high.

Via The Motley Fool

Novo Nordisk Charts Signal Weakness Amid Wegovy Warning, Expert Says 'Could've Played Out VERY Differently If They Had Embraced $HIMS' ↗

July 30, 2025

Novo Nordisk's technical chart is displaying a largely bearish trend amid a profit warning tied to its blockbuster obesity drug Wegovy.

Via Benzinga

Unitedhealth, Starbucks, Novo Nordisk, UPS And Meta: Why These 5 Stocks Are On Investors' Radars Today ↗

July 29, 2025

UNH, SBUX, NVO, UPS, META were among the stocks seen trending on Tuesday, July 29, 2025.

Via Benzinga

Why Eli Lilly Stock Was Looking Sickly Today ↗

July 29, 2025

It seemed the market overreacted to discouraging news from one of the company's rivals.

Via The Motley Fool

History of Novo Nordisk A/S Stock: From Insulin Pioneers to Global Pharma Leader (NYSE:NVO)

July 29, 2025

Novo Nordisk A/S (NYSE:NVO) has evolved over the past century from a humble insulin manufacturer in Denmark into one of the world’s most valuable pharmaceutical companies. With a commanding presence in...

Via MarketMinute

Topics Economy Emissions

Novo Nordisk Shares Plunge Amid Leadership Shakeup (NYSE:NVO)

July 29, 2025

In a surprising turn of events, shares of pharmaceutical giant Novo Nordisk (NYSE:NVO) fell sharply following the company’s announcement of a significant leadership restructuring. The abrupt changes at...

Via MarketMinute

Topics ETFs Economy

Why NovoCure Stock Is Cratering Today ↗

July 29, 2025

The Ozempic maker's stock is dropping fast -- here's why.

Via The Motley Fool

Topics Stocks

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.